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Abstract—This study was aimed at simulating the effect of
various treatment parameters like heating rate (HR), peak
temperature (PT) and hold/total treatment time on the
viability of human liver cancer HepG2 cells subjected to
different thermal therapy conditions. The problem was
approached by investigating the injury kinetics obtained
using experimentally measured viability of the cells, heated to
temperatures of 50–70 C for 0–9 min at HRs of 100, 200, 300
and 525 C min
)1. An empirical expression obtained between
the activation energy (E) and HR was extended to obtain the
E values over a broad range of HRs from 5 to 600 C min
)1
that mimic the actual conditions encountered in a typical
thermal therapy protocol. Further, the effect of the HR (5–
600 C min
)1) and PT (50–85 C) on the cell survival was
studied over a range of hold times. A signiﬁcant drop in
survival from 90% to 0% with the simultaneous increase in
HR and PT was observed as the hold time increased from 0
to 5 min. For complete cell death, the hold time increased
with the increase in the HR for a given PT, while the total
time showed presence of minima for 60, 65 and 70 C at HRs
of 50, 100 and 200 C min
)1, respectively.
Keywords—Heating rates, Peak temperatures, Hold time,
Total treatment time, Minimal treatment time, Injury kinet-
ics, Arrhenius model, Clinical protocols.
INTRODUCTION
Primary liver cancer is the ﬁfth most common
malignancy in the world, with a global annual incidence
of about one million new patients.
6 In 2004, the
American Cancer Society estimated 18,920 new cases of
Hepatocellular Carcinoma (HCC) and the estimated
deaths were 14,720.
1 Surgical resection, the gold
standard for the treatment of primary liver can-
cer, shows low success rate (20–37%) and a high recur-
rence (50–60%) rate due to many surgical complica-
tions.
10,25 Liver transplantation is limited because of
fewer donors.
18 Combination treatment methods, using
chemotherapy, embolization and chemoembolization
havealimitedeffecteven withthe newer drugsavailable
and their beneﬁcial effects on the patient survival re-
main controversial in randomized studies.
18,24 Use of
radiation therapy is limited to alleviating the symptoms
such as pain or just to shrink the tissue rather than
destroyingit.Ablationtherapiesthatuseheattodestroy
the tumor are gaining increasing attention as an alter-
native because the treatment procedure is faster, sim-
pler, less painful and cheaper.
20
There are two known approaches for the applica-
tion of these ablative procedures: hyperthermia, where
the treatment modalities use temperatures ranging
from 42 to 50 C for periods of 30 min to few hours.
Another approach is thermal therapy, where the
destruction of the tumor takes place by the application
of heat at temperatures higher than 50 C within very
short time periods of few minutes to seconds. The
tumor is heated using any one of radiofrequency,
microwave, laser or high intensity focused ultrasound
energy sources. Several clinical trials have been per-
formed to test the eﬃcacy of these thermal ablative
therapies in treatment of liver cancer using the above-
mentioned energy sources. The results have shown
survivals of 83–94% after 1 year, 50% after 2 years,
33% after 3 years and 33–40% after 5 years for
hyperthermic radiofrequency ablation in studies con-
ducted on 29–123 patients.
18 Survival of 86% after
1 year in 55 patients has been reported for hyperther-
mic interstitial laser therapy;
12 survivals of 73–86%
after 3 years,
18 50% after 4 years and 48.6% after
5 years
17 have been reported for microwave coagula-
tion therapy. In spite of all the above-mentioned clin-
ical trials, no data exists showing the effect of thermal
therapy on the survival of liver cancer cells. Effect of
hyperthermic temperatures on human liver cancer cell
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1745lines has also been investigated in few in vitro studies.
Callari et al.
7 used HTC hepatoma cells to study the
action of retinol on viable cell recovery after in vitro
hyperthermia at temperatures between 42 C and 44 C
for 1 h. Hasumura et al.
13 studied the effect of TNF
along with hyperthermia on JHH-4, JHH-5 and JHH-7
human hepatoma cells between temperatures of 41.4 C
and 42.5 C. However, none of the studies demon-
strated the effect of temperatures above 50 C any liver
cancer cell lines.
Since in thermal therapy, the injury accumulates at
very high temperatures within a short period of time,
knowledge of the injury kinetics is very useful for
predicting the cell/tumor damage
15 for these thermal
histories. Several thermal therapy studies have been
performed to obtain the injury kinetics in different
cell lines. Landry et al.
19 heated HeLa cells up to
55 C using water bath, with thermal equilibrium time
of 1 min for 55 C. To reduce this equilibrium time
Borrelli et al.
5 heated cells to 57 C on 0.025-mm thick
mylar pieces. Cell injury kinetics was obtained by
measuring the cell survival using clonogenic assay in
both the studies. In addition, studies on T24 human
bladder carcinoma,
22 skeletal muscle,
11 SN12 renal
cell carcinoma
15 and Dunning AT-1 prostate cancer
cells
4 in the temperature range of 40–70 C obtained
cell injury kinetics using dye uptake assays and
thus showed that dye uptake assay is a reasonable
conservative estimate of the cell survival. Also, two
recent in vitro studies in human benign prostatic
hyperplasia tissue and rodent prostate cancer tissue
showed that the cell injury kinetics measured by
membrane integrity vital dye assay and histology
assays are very similar.
2,3 Therefore, a key observa-
tion from the above studies is that vital dye uptake
assay can be used as an alternate and reliable con-
servative maker as it provides rapidity, automation
and better control.
15
A key diﬀerence of high temperature–short
time thermal therapy protocols from the traditional
hyperthermia protocols is the signiﬁcant injury
accumulation during the non-isothermal portion of
the thermal history (heating up/cooling down peri-
od). Therefore, injury accumulation tends to be a
complex function of hold time as well ramp up and
cooling time. Hence, accurate prediction of the cell
injury kinetics requires the knowledge of heating/
cooling rates in addition to peak temperatures (PTs)
and hold/total time. This model also better repre-
sents the thermo-clinical applications because the
rate at which the PTs are achieved at diﬀerent
locations inside the tumor vary with the applicator
location and plays a paramount role in determining
the amount of injury accumulated. The knowledge of
the injury accumulated in reaching a PT or the PT
required to obtain a desired injury under diﬀerent
heating rates (HRs) are some of the very important
parameters in designing better and optimal clinical
protocols.
This study was used to investigate experimentally
and through simulations the parameters aﬀecting
thermal therapy of primary human liver cancer HepG2
cells between 50 C and 70 C using Ethd-1 uptake cell
membrane integrity assay. The cells were thermally
challenged on a programmable heating stage which can
control and record the entire thermal history proﬁle,
allowing us to recreate typical thermal therapy proto-
cols. Cell membrane integrity dye uptake (Ethd-1) was
used as an irreversible injury marker. The ﬁrst-order
Arrhenius rate model was used to extract the kinetic
parameters activation energy, E (kJ mol
)1) and fre-
quency factor A (s
)1).
16 The survival data was ﬁtted
into the Arrhenius model for various HRs and the E
and A values were predicted by minimizing the least
square between the model predictions and the experi-
mental data for suspended and attached cells. Based on
the predicted E values, a relationship between the E and
HR was obtained experimentally and was further used
to simulate the survival map for different hold periods
by varying the target PT and the HR. Finally, the hold
time and the total injury time necessary for complete
cell death (Survival£0.001%) was predicted for target
PTs of 60–85 C and HRs of 5–600 C min
)1 repre-
senting the typical transient thermo-clinical protocol.
MATERIALS AND METHODS
HEPG2 Cell Culture and Sample Preparation
Human liver cancer Hepg2 cells (ATCC, VA) were
propagated in MEM cell culture media with 10% Fetal
Bovine Serum (Hyclone, UT) and 1% penicillin/strep-
tomycin (Invitrogen, CA). They were then incubated in
10% CO2 and 95% humidiﬁed air at 37 C in 75-cm
2 T
ﬂasks. The cells were trypsinized with Trypsin-EDTA
(ATCC, VA) for 5–10 min, centrifuged at 1200 rpm
for 5 min and re-suspended in the media to an
appropriate concentration. Suspended cell samples
were prepared by placing 3 ll of cell suspension onto
the center of the 12-mm diameter coverglass, covering
it with another coverglass to prevent evaporation
during heating. For attached cell studies, cell suspen-
sion was scattered over about 18–20, 12-mm cover
glasses lying in a 110-mm diameter Petri dish. Over-
night attachment of the cells on top of the coverglass
was allowed in the incubator and then the cell sample
was prepared in the same way as the suspended
sample.
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Attached and suspended cell samples were heated
on a programmable heating stage, at diﬀerent HRs.
Figure 1 shows the setup diagram of the heating stage
and the feedback control used. Cement T-type ther-
mocouple (Omega Engg Inc., CT) was used for tem-
perature detection, which is interfaced with a data
acquisition board (DAB) (Keithly Inc., Cleveland,
OH) connected to the computer port. The interface
between the user and the DAB is through a Visual
Basic code that calculates the output voltage based on
the set point and instantaneous temperature and con-
trols it based on proportional and derivative constants
used in the feedback loop. Table 1 shows the combi-
nations of proportionality (kp) and derivative (kd)
constants used in the feedback loop to achieve different
HRs (100, 200, 300 and 525 C min
)1). An OPAMP
(Analog Devices Inc, MA) circuit is used to amplify the
feedback voltage signal from the DAB and heat the
stage. The stage was calibrated using ﬁxed temperature
tempi labels and sticks (MSC Industrial Supply Co.,
NY) to an accuracy of ±0.3 C for all PTs at each HR
used in the study.
Heating Studies and Ethd-1 Dye Uptake Assay
Suspended and attached HepG2 cell samples were
heated to diﬀerent time–temperature histories. Iso-
thermal heating was carried out for suspended and
attached cells at temperatures between 50 Ca n d7 0  C
for 0.5–9 min. The cell sample was placed on the center
of the heating stage after the PT was reached. The time
for each cell sample to equilibrate to any given PT was
experimentally calculated to be  5 s and was added to
the hold time during heating. HRs of 100, 200 and
300 C min
)1 were employed for heating attached cells
non-isothermally between temperatures of 60 C and
70 C for a hold time of 0–3 min using the entire tem-
perature–time history, which includes the rise, hold
and the cooling period. The HRs were assumed to
be constant for the entire thermal history and were
obtained by taking a tangent to the exponential curve
of the temperature rise. Therefore, the cell sample was
placed on the center of the heating stage before starting
FIGURE 1. Block diagram of the amplifying OPAMP circuit and feedback control of the heating stage. The OPAMP circuit
ampliﬁes the voltage signal from the data acquisition board to heat the stage, while the feedback control system, through the VB
code, controls the amount of voltage based on the instantaneous temperature of the stage.
Table 1. Values of proportionality (kp) and derivative (kd)
constants for different HRs to obtain desired PTs.
HR ( C min
-1)P T (  C) kp kd
100 60 0.0155 0.0925
65 0.0155 0.0925
70 0.0155 0.0925
200 60 0.035 0.108
65 0.035 0.108
70 0.035 0.121
300 60 0.085 0.255
65 0.085 0.255
70 0.0903 0.275
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from a given PT was calculated based on the experi-
mentally measured cooling rate of 100 C min
)1.
Cellular injury post heating for isothermal and non-
isothermal studies was quantiﬁed using Ethd-1 (Sigma-
Aldrich, MO) vital dye assay by counting the number
of cells stained with Ethd-1 dye (dead only) and the
total number of the cells stained with Hoechst (Sigma-
Aldrich). Thermally treated cell samples were placed in
a5 0ll drop of 2.5 lM Ethd-1 and 10 lM Hoechst dye
solution in a 35-mm Petri dish and incubated for 3 h.
The incubation time of 3 h was based on the experi-
ments conducted after 1, 2 and 3 h of incubation (data
not included), which conﬁrmed that membrane dam-
age equilibrates within this period and a signiﬁcant
amount of media is pulled between the cover glasses to
stain the cells. Control samples underwent the same
procedure without heating. After 3 h, the dead and the
total number of cells were counted with a ﬂuorescent
microscope (Nikon Eclipse TS 100, Tokyo) using a
20  objective. Multiple ﬁelds with at least 150–300
cells were counted for each run.
Normalized Cell Survival
For all the cell samples, the normalized cell survival
(Se) was calculated as follows:
Se ¼ (NH;t   NE;t)/NH;t
    
(NH;c   NE;c)/NH;c
  
ð1Þ
NH and NE are the number of total and dead cells
stained with Hoechst and Ethd-1 respectively; sub-
scripts ’t’ and ’c’ represent thermally treated and con-
trol cells, respectively. The calculated cell survival was
based on three separate experiments, with two runs for
every data point in each experiment.
The Cell Injury Model
Thermally induced cellular injury was considered as
a ﬁrst-order irreversible process as shown below and as
used in many previous heating studies;
V !
k
I ð2Þ
where V represents the viable state of a cell, I repre-
sents the injured state of a cell and k is the cell injury
rate. The predicted cell viability (Sc) was calculated
using the following equation:
Sc ¼ exp  
Zd
0
kdt
0
@
1
A ð3Þ
d is the total treatment time (s).
The Arrhenius model
16 was adopted in this study
as it has been extensively used in previous studies to
obtain the cell injury kinetics
14,21 as shown below;
k ¼ Aexp
 E
RT
  
ð4Þ
A is frequency factor (s
)1), E is activation energy
(J mol
)1) and R is the universal gas constant
(8.314 J mol
)1 K
)1). A and E are related by an
empirical formula, obtained by compiling the injury
kinetics of various proteins, cells and tissues.
15
lnðAÞ¼0:38E   9:36 ð5Þ
Determination of Arrhenius Model Parameters
The kinetic parameters E and A were determined by
ﬁtting Eqs. (4) and (5) in Eq. (1) as obtained by He and
Bischof
15 They were further reﬁned using a simple
optimization subroutine to minimize the root mean
square error between the experimental data and model
prediction.
fðXÞ¼
1
N
X n
i¼1
Se;iðXÞ Sc;iðXÞ
   2
"# 0:5
ð6Þ
N is the total number of data points, vector ’X’ con-
tains variables E and A. Se,i and Sc,i represent the ith
measured data point and model ﬁt, respectively. The
goodness of the ﬁt (R
2) is calculated as follows:
R2 ¼ 1  
P
Se;iðXÞ Sc;iðXÞ
   2   
P
Se;iðXÞ Sav
   2    ð7Þ
Sav is the measured average survival from the Etdh-1
studies.
RESULTS
The results were generated by counting the number
of total and dead cells from the micrographs of the cell
samples as shown in Fig. 2 and using Eq. (1) to cal-
culate the normalized cell survival for each sample.
Figure 2a, b represent the control sample, where the
number of dead cells, stained with Ethd-1 (red) dye, is
very less compared to the total number of cells, stained
with Hoechst (blue) dye and the cell survival is higher
than 0.96. The cell survival decreases slightly as the
number of dead cells compared to the total number of
cells increases for the cell sample heated at 50 C for
9 min, as shown in Fig. 2c, d. The survival drops
dramatically with a sharp increase in the number of
B. SHAH and S. BHOWMICK 1748dead cells compared to total cells at 70 C as seen in
Fig. 2e, f.
Isothermal Heating Studies
The isothermal heating studies were used to under-
stand the eﬀect of diﬀerent temperature–time histories
on the viability of attached and suspended HepG2 cells
and to quantify the cellular injury associated with these
histories. All the cell samples reached the PTs in  5s
at an approximate HR of 525 C min
)1 resulting in a
negligible difference between the hold time and the
total time of the treatment. Thus heating at the rate of
525 C min
)1 was referred as isothermal heating.
The data in Fig. 3a, b represents the mean and the
standard error for measured cell viability of attached
and suspended HepG2 cells respectively using Ethd-1
dye uptake assay. Both the ﬁgures show that for a
given PT, the survival drops with the increase in the
hold time. At 50 C, the survival drops from 0.84 to
0.43 for suspended cells and from 0.89 to 0.62 for
attached cells, as the hold time increases from 2 to
9 min. Similar trend was observed for heating at all the
PTs. The ﬁgures also show that for a given hold time,
the cell survival drops with the increase in the PT for
suspended cells. For a hold time of 2 min, the cell
survival drops from 0.84 to 0.52 and from 0.52 to 0.29
as the PT increases from 50 Ct o5 5  C and from 55 C
to 60 C, respectively. For a hold time of 1 min, the cell
survival drops from 0.45 to 0.1 and from 0.1 to 0.003
as the PT increases for 50 Ct o5 5  C and from 55 Ct o
60 C, respectively. The same trend is also seen for the
attached cells but with slightly higher survival.
The ﬁgures also show the eﬀect of PTs on the slope
of the survival curve. The drop in the survival with the
increase in the hold time is slow at low PTs. The sur-
vival curve gets steeper as the PT increases. When
heated at 50 C for up to 9 min, the cell survival is still
higher than 0.43 for both suspended and attached cells.
This trend changes for 55 C, where the cell survival
drops to 0.03 after only 6 min of heating. This trend
magniﬁes sharply as the PTs increases to 60, 65 and
70 C. For suspended cells, the survival at 60 C varies
from 0.58 to almost zero survival as the hold time
increases from 0.5 to 3 min. The survival dropped from
0.2 to 0.003 for an increase in the hold time from 15 s
to a min at 70 C. The attached cells also showed a
similar trend with slightly higher survival than the
suspended cells for all the data points.
The student t-test assuming unequal variance was
used to observe the statistical signiﬁcance between the
experimentally measured cell viability of suspended
and attached HepG2 cells as shown in Fig. 3c. With
p = 0.05 as the criterion, no signiﬁcant difference in
the cell viability was observed for most of the data
points. The data points that were signiﬁcantly different
(p < 0.05) are 50 C – 5 min, 50 C – 9 min, 60 C–
3 min and 70 C – 1 min. This difference for data
points of 60 C – 3 min and 70 C – 1 min can be
neglected as the experimentally calculated cell viability
in suspended and attached HepG2 for both these
thermal insults is of the order 10
)3. The p-value of
0.088 for 60 C – 2 min data point suggests the differ-
ence in the cell viability is not signiﬁcant, but is still
different. As no signiﬁcant difference between the
survival of suspended and attached HepG2 cells was
observed for most of the time–temperature histories
and since attached cells better describe the arrange-
ment of the cells in a tissue, only attached cells were
used for further non-isothermal studies.
FIGURE 2. Micrographs showing cell samples stained with Hoechst (Blue-all cells) and Ethd-1 (Red-dead cells only). (a and b) –
control samples without heating; (c and d) – samples heated at 50 C for 9 min; (e and f) – samples heated at 70 C for 1 min.
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FIGURE 3. (a) Plot of experimentally measured and predicted survival of attached cells heated isothermally versus hold time in
minutes for single cell heating at PTs of 50, 55, 60, 65 and 70 C. Cross ( ), ﬁlled circles ( ), ﬁlled diamonds (¤), ﬁlled squares (n)
and ﬁlled triangles (m) represents heating of samples at 50, 55, 60, 65 and 70 C, respectively. The lines represent the exponential ﬁt
through all the data points based on the predicted E and A values. (b) Plot of experimentally measured and predicted survival of
suspended cells heated isothermally versus hold time in minutes for single cell heating at PTs of 50, 55, 60, 65 and 70 C. Cross ( ),
ﬁlled circles ( ), ﬁlled diamonds (¤), ﬁlled squares (n) and ﬁlled triangles (m) represents heating of samples at 50, 55, 60, 65 and
70 C respectively. The lines represent the exponential ﬁt through all the data points based on the predicted E and A values. (c)
Direct comparison between suspended and attached HePG2 cell viability, using student t-test assuming unequal variance. Each
data point is an average of three separate runs using two different cell samples for each run. The error bar in the ﬁgure represents
the standard error of the mean. Data points marked with asterisks indicate the data points where viability of suspended and
attached cells is signiﬁcantly different.
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by ﬁtting the Arrhenius rate model into the survival
data. This was done by minimizing the function in Eq.
(6) using Eqs. (3) and (4). The predicted E and A values
for suspended and attached cells for isothermal heating
are shown in Table 2. The E and A values obtained for
suspended cells are 229.46 (kJ mol
)1) and 3.495 10
31
(s
)1) and those for attached cells are 248.64 (kJ mol
)1)
and 5.396 10
36 (s
)1), respectively. The predicted
survival based on the predicted E and A values for
attached and suspended cells is shown by the solid lines
in Fig. 3a, b, respectively. The goodness of the ﬁt
between the predicted and experimentally measured
values, obtained using Eq. (7) for suspended and at-
tached cells, is 0.86 and 0.84, respectively.
Non-Isothermal Heating Studies
The study focused next on the investigation of the
eﬀect of diﬀerent HRs on the cell viability of attached
HepG2 cells and extraction of kinetic parameters of
the cellular injury associated with each HR. The
HRs of 100, 200 and 300 C min
)1 were employed in
this study, as they all showed a considerable difference
in the rise-time at all the PTs. The total injury time
(rise, hold and cooling time) was taken into account to
quantify the thermal injury for all the HRs.
The data in Fig. 4a–c represents the mean and the
standard error of the measured cell viability using
Ethd-1 dye uptake assay for attached HepG2 cells at
HRs of 100, 200 and 300 C min
)1, respectively. All
the ﬁgures show that, for a given HR, the cell survival
drops with the increase in the hold time and the PT,
similar to that observed in isothermal heating. At the
HR of 100 C min
)1, the survival drops from 0.82 for
Table 2. Activation energy E (kJ mol
)1) and frequency factor
A (s
)1) using all the data point for different HRs.
HR ( C min
)1) Activation
energy E
(kJ mol
)1)
Frequency
factor A (s
-1)
100 272.4 7.757 10
40
200 262.02 1.502 10
39
300 257.38 2.576 10
38
525 (Isothermal – Attached) 248.64 5.396 10
36
525 (Isothermal – Suspended) 229.46 3.495 10
31
FIGURE 4. Plot of experimentally measured and predicted survival of attached cells heated at various heating rates versus time in
minutes for single cell heating at temperature 60, 65 & 70 C. (a) 100 C min
)1. (b) 200 C min
)1. (c) 300 C min
)1. Filled diamonds (¤),
ﬁlled squares (n) and ﬁlled triangles (m) represents heating of samples at 60, 65 and 70 C respectively. The lines represent the
exponential ﬁt through all the data points based on the predicted E and A values.
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of 60 C. This trend remains the same for the PTs of
65 C and 70 C and for all the HRs. The survival
drops from 0.82 at 60 C to 0.69 at 65 C and further to
0.11 at 70 C, for no hold time at HR of 100 C min
)1.
This trend continues for all the HRs and at all the
hold times. The ﬁgures also illustrates that for any
given PT and for a given hold time, the cell survival
increases with the increase in the HR. At 60 C for no
hold time, the survival increases from 0.82 at
100 C min
)1 to 0.85 at 200 C min
)1 and further to
0.88 at 300 C min
)1.A t6 5  C for a hold time of
0.5 min, the survival increases from 0.15 at
100 C min
)1 to 0.19 at 200 C min
)1 and then to 0.22
at 300 C min
)1. This trend also continues for 70 C for
any given hold time.
A trend was observed in the Arrhenius parameters
obtained from the non-isothermal heating studies as
the E, and the corresponding A value, decreased with
the increase in the HR. Table 2 shows the predicted E
and A values for HRs of 100, 200 and 300 C min
)1.
The activation energy decreases from 272.40 kJ mol
)1
at 100 C min
)1 to 262.02 kJ mol
)1 at 200 C min
)1
and then to 257.38 kJ mol
)1 at 300 C min
)1. The solid
lines in the Fig. 5a–c represent the predicted cell sur-
vival based on above values respectively. The goodness
of ﬁt between the predicted and measured cell survival
for all data points obtained using Eq. (7) is 0.97 for all
the HRs used in this study.
Relation Between Activation Energy and HRs
The following relation was obtained by ﬁtting a
polynomial trend line through the data in Table 2 that
includes the isothermal heating at 525 C min
)1;
E ¼ 0:0001ðHRÞ
2   0:1173ðHRÞþ282:67 ð8Þ
E represents the activation energy and HR represents
the HR. The above equation was then used to obtain
the values of activation energy over a range of HRs
from 5 to 600 C min
)1 in order to simulate the effects
of various parameters on the cell survival. The values
of the activation energy shows a small decrease from
282.09 to 248.29 kJ mol
)1 over a large increase in the
HR increased from 5 to 600 C min
)1.
Eﬀects of PTs, HRs and Hold Time on the Cell Survival
Based on the E and A values obtained at HRs of 5–
600 C min
)1 using the E–HR relation, the cell survival
was predicted at different hold times for PTs between
50 C and 85 C. The combined effect of the increase in
the hold time and PT on the cell survival is shown in
the Fig. 5a–d for all the HRs mentioned above.
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FIGURE 5. Plot of the normalized survival of attached cells for various hold times at different peak temperatures and heating rates
based on the predicted E and A values. (a) 0 min. (b) 0.25 min. (c) 1 min. (d) 5 min.
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drops consistently with the increase in the PT. For a
HR of 20 C min
)1, the cell survival drops from 0.98 at
50 C to 0.091 at 65 C and then to no cell survival at
temperature above 75 C, when the hold time is 0 min.
The trend remains the same for any HR and hold time
combination. The drop in the cell survival for any hold
time is lower when the PTs are 55 C and less. The
survival drops slightly from 0.96 at 50 C to 0.84 at
55 C for heating at 200 C min
)1 for a hold time of
1 min. This drop is higher, from 0.84 to 0.48, when the
temperature increases to 60 C. This trend is magniﬁed
with the increase in the PT to 65 C where the survival
drops to 0.05 and to almost complete cell destruction
for a further 5 C rise in the PT. At any given hold time
and PT, the cell survival increases with the increase in
the HR. The survival increased from 0.006 to 0.56 at
60 C for a hold time of 1 min and from 0 to 0.002 for a
hold time of 3 min at 65 C as the HR increased from 5
to 600 C min
)1.
For a given PT and a HR, the cell survival drops
with the increase in the hold time. At 60 Ca n d
50 C min
)1 the cell survival drops from 0.76 to 0.008
when the hold time increases from 0 to 5 min. For the
same increase in the hold time, the survival drops from
0.12 to zero at 70 C and 400 C min
)1. For any hold
time, almost complete cell destruction takes place at all
the HRs when the PTs are 75 C and above. For HRs
of 50 C min
)1 and lower, the PT to acquire almost
complete cell death decreases with the increase in hold
time. For zero hold time, 70 C shows a survival of
0.004 and less for HRs of 50 C min
)1 and less. When
the hold time is 1 min, complete cell death is observed
at 65 C for all the HRs below 50 C min
)1 and at 60 C
for HR of 5 C min
)1. The survival at 55 C decreases
considerably with hold time at these low HRs but is
still signiﬁcantly high (>10%), while the survival at
50 C shows a very less drop. For a HR of 10 C min
)1,
the survival at 55 C drops from 0.79 to 0.28 with the
increase in the hold time from 0 to 5 min. At 50 C, this
drop is from 0.96 to 0.79. This trend is depicted
in Fig. 5a–d as the drop in the slope of the vertical
portion with the increase in the hold time.
Hold and Total Injury Time for Complete Cell
Destruction
The relationship between activation energies and
HRs was further used to predict the hold time and
total injury time required to attain complete cell
destruction at diﬀerent target PTs and HRs that rep-
resents diﬀerent scenarios of a clinical thermal therapy
protocol. Figure 6a, b shows the calculated hold
time and total time in minutes resulting in complete
cell death at target PTs between 60 C and 85 Ca n d
HRs between 5 and 600 C min
)1, which represents the
transient clinical problem strictly under thermal ther-
apy conditions.
Figure 6a shows that, for a given target PT, the hold
time increases with the increase in the HRs. It increases
from 0.45 to 8.4 min, from 0 to 2.2 min, from 0 to
0.61 min, from 0 to 0.17 min and from 0 to 0.05 min at
a target PT of 60, 65, 70, 75 and 80 C, respectively.
The increase in the hold is negligible at 85 C. Further,
the hold time decreases with the increase in target PT,
for any given HR. At 300 C min
)1 the hold time for
complete cell destruction decreases from 7.2 min at
60 C to 0.4 min at 80 C. For very low HRs of 5 and
10 C min
)1, complete cell destruction is achieved for
target PTs of 65 C and above without any hold time.
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FIGURE 6. (a) Plot of hold time in minutes to attain complete
destruction of attached HepG2 cells at various PTs between
50 C and 85 C and at HRs from 5 to 600 C min
)1. (b) Plot of
total time (min) to attain complete destruction of attached
HepG2 cells at various PTs between 50 C and 85 C and at HRs
from 5 to 600 C min
)1 .
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are 70 C and above at 20 C min
)1 and 75 C and above
at 50 C min
)1. Heating, targeted at PTs of 80 Ca n d
85 C, kills all the cells without any hold period for any
of the above used HR. These results demonstrate that
signiﬁcant cell death takes place during the ramp up
and ramp down period.
Figure 6b shows the variation in the total injury
time (rise, hold and cooling time) to achieve complete
cell destruction with the change in the target PTs and
HRs. For 60, 65 and 70 C, the total injury time showed
a minima with the decrease in the HR. For example,
the total time at the target PT of 60 C, decreases from
8.8 for 600 C min
)1 to 5.9 for 50 C min
)1 and then
again increases to 7.8 min for 5 C min
)1.A t6 5  C, the
total time decreases from 2.7 min to 2 min and then
increases to 3.2 min for a decrease of HR from 600 to
100 C min
)1 and again to 20 C min
)1, respectively.
The trend remains the same at 70 C, the transition of
hold time being at a higher rate of 200 C min
)1. For
target PTs of 75, 80 and 85 C, this trend reverses as the
total injury time consistently increases with the
decrease in the HR, unlike for all other target PTs. The
total time increased almost twice from 0.76, 0.69 and
0.7 at 75, 80 and 85 C respectively, as the HR dropped
from 600 to 50 C min
)1. For the target PTs (85 Ct o
65 C) where no hold time is required to attain com-
plete cell death, total injury time was obtained as 1,
1.35, 2.4, 3.96 and 6.93 min at HRs of 100, 50, 20, 10
and 5 C min
)1, respectively. The trend in the change of
the total injury time with change in target PT, for any
given HR remains the same as that for the hold time.
DISCUSSION
Injury Kinetics of Attached and Suspended Cells
The comparison of the survival data for the
suspended and the attached cells (Fig. 3a, b) indicate
that the suspended cells are a slightly more susceptible
to heat than the attached ones. He and Bischof
15 also
obtained similar results for SN12 human renal cell
carcinoma within the same temperature range, where
the reason for this difference between suspended and
attached cells was assumed to be the difference in
their protein synthesis and gene expression. It may be
assumed that some of the above differences also exist
between attached and suspended HepG2 cells used in
this study. The results shows a clear difference
between the frequency factors for both the cell types,
but the activation energies does not show much
variation. But since the difference in the survival of
suspended and attached cells is small either of the cell
type can be used in studying the cell injury kinetics in
HepG2 cells.
Comparison with Previous Hyperthermic Studies
Hyperthermic studies are mainly characterized by
the presence of a shoulder region followed a slope in
the survival curve. In these studies, the shoulder region
is typically associated with considerably higher ( 30–
40%) cell survival within a long heating period of few
hours and has been observed in the temperature range
of 42–45 C in many studies. Chinese hamster ovary
(CHO) cells showed a small (15%) drop in the survival
followed by reduction in the slope of the survival curve
when heated at 42 C for 3 h.
9 Human melanoma
HTB-66 cells, when heated between 42 C and 45 C,
also showed a considerably high survival ( 30%) fol-
lowed by reduction in the slope at 42.5 C even after 5 h
of heating.
23 In this study, heating at 45 C for 15 min
(data not included) and at 50 C for 9 min also shows a
signiﬁcantly higher (>42%) survival for attached and
suspended HepG2 cells indicating the possibility of a
shoulder region for these short time protocols. How-
ever, whether they biologically behave in a similar
fashion to the hyperthermic shoulders by demonstrat-
ing thermotolerance has not been studied and further
investigation is clearly warranted to verify these facts.
Another important aspect of the single cell heating
studies is the presence of a break point, after which the
slope of the Arrhenius plot drops signiﬁcantly with the
increasing temperature. The break point is believed to
be the indication of an achieved thermotolerance
and change in the mechanism/target of the thermally
induced cellular injury beyond it.
9 Such break points
have been observed at 43.5 C for human cell lines
and 43 C for rodent cell lines. We have observed
no signiﬁcant break point for our studies between
temperatures of 55–70 C. However, one interesting
observation in our study was that heating at 60 C for
3 min for attached and suspended cells, shows a sud-
den change in the slope of the survival curve. The
survival drops from  0.25 at 2 min to 0.003 after
3 min of heating, suggesting the possibility of a distinct
change in the response to heating at 60 C for HepG2
cells.
Comparison of Arrhenius Parameters
This study shows a linear relationship between
activation energies and HRs for a temperature range
of 50–70 C. The activation energies between 282.09
kJ mol
)1 and 248.29 kJ mol
)1 were obtained for HRs
of 5–600 C min
)1, which are within the range of the
activation energies obtained in most of the dye uptake
assays. Thermal injury in Dunning AT-1 attached
prostate cancer cells from 40 Ct o6 0  C gave activation
energy of 245 kJ mol
)1.
4 Activation energy values
obtained in renal cell carcinoma studies are 290–
360 kJ mol
)1.
15 and in skeletal muscle tissue is
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)1.
11 The activation energies for clonogenic
assays for various studies like AT-1 prostate cancer
cells (40–70 C),
4 T24 human bladder carcinoma cells
(48–65 C) and CHO (48–65 C)
22 were found to be 500,
600 and 680 kJ mol
)1, respectively. These values are
higher than the ones obtained in this study which is not
surprising since clonogenic assay yields higher activa-
tion energies than dye uptake assays. Since the acti-
vation energies obtained in this study are in the same
range of the values obtained for other dye uptake
assays, we suggest that the mechanism of thermal
injury and its measurement is consistent with other
studies.
Clinical Relevance
Clinical thermal therapy is a transient conduction
problem as the tumor gets heated by deposition of
energy from the source and by diﬀusion of the heat
from the applicator. Based on the size and heat
absorption pattern of the tumor, diﬀerent radial loca-
tions are heated to diﬀerent PTs at diﬀerent rates. The
regions closer to the applicator gets heated to higher
PTs at higher HRs than the ones that are further away
resulting in diﬀerent survival patterns at various loca-
tions inside the tumor. Thus, accurate prediction of the
hold time of the applicator inside the tumor is very
important to ensure desired cellular injury accumula-
tion at every location. As in these high temperature–
short time thermal therapy protocols a considerable
(>10%) injury accumulates within the non-isothermal
portion of the thermal history, the determination of the
total treatment time (rise, hold and cooling) is also
necessary to obtain desired injury accumulation. Since
the maximum size of a liver tumor that can be treated
using various energy sources is limited to 4–6 cm
diameter,
8 the HRs between 600 C min
)1 and
5 C min
)1 are representative of all the locations within
the tumor for any selected energy source, while the
temperatures between 85 C and 50 C are descriptive
of the actual temperature distribution inside the
tumor during the thermal application. Temperatures
higher than 85 C might result in carbonization near
the applicator as well as overheating of the healthy
tissue beyond the edge of the tumor, while tempera-
tures lower than 50 C may result in insufﬁcient injury
accumulation within the short treatment time. There-
fore, design of clinical thermal therapy protocols
requires knowledge of the survival patterns for differ-
ent hold times and precise prediction of hold and total
treatment times to obtain desired cellular injury within
the above mentioned range of HRs and PTs.
Such an attempt has been made in a previous
study carried out by He and Bischof
15 on SN12 renal
cell carcinoma. The cell injury kinetics, based on the
non-isothermal heating at an average rate of
100 C min
)1, were used to predict the PTs necessary to
obtain a considerable (>10%) amount of cellular in-
jury in cells during the rise period. This prediction was
extended to various HR–activation energy combina-
tions just by selecting HRs between 2 C min
)1 and
200 C min
)1 and activation energies up to
1000 kJ mol
)1. However, experimental calculations to
determine E as a function of HRs was not included in
above study. The unique feature of this study is that
for all PTs, prediction of survival and treatment time
at any given HR is based on a speciﬁc experimentally
calculated E–A combination for that HR, which results
in a close approximation of the actual cellular injury
for these high temperatures-short time thermal treat-
ments.
An important assumption made in this study is that
the HR used to attain a target PT remains constant.
The temperature rise on the heating stage, based on the
constants kp and kd in the feedback loop, was found to
be exponential. The HR was approximated by taking a
tangent to the temperature–time curve, resulting in a
constant value for the entire temperature rise. How-
ever, inside a tumor, the bioheat equation is required
to model the transient temperature rise which is rarely
linear. But as an initial step in understanding the effect
of important parameters governing thermal therapy,
this assumption may be a good approximation to
predict desired cellular injury and Figs. 5 and 6 may
provide important insights in this direction.
The predicted survival at diﬀerent hold times in
Fig. 5a–d shows that for any HR, the PT required to
attain a considerable amount of injury accumulation
(>90%) decreases as the hold time increases. A smaller
ﬂat portion representing complete cell death and the
steeper vertical portion representing considerable
(>10%) survival for zero hold time in Fig. 5a inter-
sects at 70 C and complete cell death is observed for
HRs of 50 C min
)1 and lower. This suggests that for
HRs of 50 C min
)1 and lower, typically at the
boundary of the tumor, PTs of only 70 C and above
are capable of accumulating signiﬁcant amount of in-
jury. This information is helpful in developing treat-
ment protocols for small sized tumors, where the use of
high target PTs will not signiﬁcantly damage the
healthy tissue beyond the range of the tumor, even
though the temperatures at those locations are higher
than 60 C. As the hold time increases the intersection
shifts toward lower PTs increasing the ﬂat portion of
complete cell destruction. The decrease in steepness of
the vertical portion also implies that sufﬁcient cell
damage can be obtained at tumor boundaries at these
low temperatures. For example, when the hold time is
5 min, more than 80% survival is observed even at
55 C at the boundary of the tumor where the HR is as
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)1. This shows that thermal protocols
with higher hold times are beneﬁcial for cell injury in
large size tumors. Since it is necessary that the inter-
section should coincide with the tumor boundary to
maximize the damage within the tumor as well as
minimize the damage of the surrounding healthy tis-
sue, the contours obtained in Fig. 5a–d are very
important in the selection of the hold times based on
the size of the tumor.
Since the goal of every clinical application is com-
plete tumor destruction, it is very important to know
the hold time required to destroy all the tumor cells for
diﬀerent PT–HR combinations (that may represent
diﬀerent regions within a tumor depending upon its
geometry and the energy source used). Figure 6a
shows the hold time necessary to acquire complete
damage in attached HepG2 cells at PTs between 60 C
and 85 C and HRs between 5 C min
)1 and
600 C min
)1 and suggests that the hold time increases
with the simultaneous decrease in the PT and the HR.
Therefore, as the distance from the applicator in-
creases, decreasing the PT and the HR, the hold time
for tumor destruction increases. For example, Fig. 6a
shows that the hold time increases from almost zero at
85 C – 500 C min
)1 to 4.84 min at 60 C–5 0  C min
)1.
Signiﬁcant increase in the hold time for PTs of 60 C
and 65 C suggests that in the regions away from the
applicator (HRs of 100 C min
)1 and lower), the injury
accumulation strongly depends on the hold time.
However, the hold time is very less for PTs of 70 C
and above even at high HRs and decreases to almost
zero as the HR decreases, suggesting that the majority
of the cell damage at these temperatures occurs just
within the rise and cooling period. At 70 C and above
for HRs of 20 C min
)1 and lower, the hold time
completely vanishes and the thermally induced cellular
injury is just a function of the non-isothermal portion
of the thermal history. Therefore it is necessary to
investigate the variation in the total treatment time
(rise, hold and cooling) to attain complete cellular
destruction at various PT–HR combinations.
Figure 6b shows the variation in the total treatment
time based on the temperature distribution within the
tumor, depending upon its geometry and the energy
source used. For PTs of 75 C and above, unlike hold
time, the total treatment time increases with the
decrease in the HR. This is due to the fact that for HRs
above 50 C min
)1, the hold time is very small and
negligible compared to the rise time to reach these high
PTs and the time to cool down back to the room
temperature. It was also observed that for a given
target PT (>70 C)–HR (<50 C min
)1) combination,
where the hold time is zero, the total treatment time
is lower than the calculated time. This suggests that
if damage within a tumor is desired at very slower
rate at PTs higher than 70 C, the tumor actually gets
destroyed before even reaching the target PT at any
location. But the interesting observation in Fig. 6b is
the presence of a minimal total treatment time at PTs
of 70, 65 and 60 C for HRs of 200, 100 and
50 C min
)1, respectively. This implies that based on
the size of the tumor and the energy source selected, if
the temperature distribution within the tumor results
in any of the above PT–HR combinations at the
boundary, complete cell death can be achieved in the
entire tumor within a minimal total treatment time.
For example, if the temperature distribution is such
that the boundary of the tumor reaches 60 Ca t
50 C min
)1, the entire tumor can be destroyed in
5.9 min. Thus based on the size of the tumor, Fig. 6a,
b may help in selecting hold and total treatment time in
order to design an optimal clinical protocol.
Since this study is based on experimental single cell
data to obtain the activation energies at diﬀerent HR,
it can serve as an accurate model for designing better
thermo-surgical protocols using appropriate energy
sources of heat delivery. Also, for a clinician practicing
the technique, it can serve as a database, from where
an optimal thermal therapy protocol can be selected
for the treatment of liver cancer. By selecting appro-
priate blood ﬂow and tissue properties and by using
the bioheat equation, this in vitro protocol can be
extended to in vivo clinical protocols.
SUMMARY
The investigation of injury kinetics in human liver
cancer HepG2 cells between temperatures of 50 Ca n d
70 C at HRs of 100, 200, 300 and 525 C min
)1 (iso-
thermal) was used to extract Arrhenius parameters, E
and A, that showed a minor decay with the increase in
the HR. The extrapolation of the kinetic parameters
over a range of heating conditions showed that the
E value decreased from 282.09 to 248.29 kJ mol
)1 as
the HR increases from 5 to 600 C min
)1. The
measured and the predicted survival at all the HRs
dropped as the PT and hold time increased. A sharp
drop in the survival was observed after 2 min of
heating at 60 C for all HRs. The measured and pre-
dicted cell survival increased with the increase in the
HR at any PTs and hold time. This increase in the
survival reduced signiﬁcantly for target PTs of 65 C
and above and for hold times of a minute and higher.
The hold time for complete cell damage decreases with
the increase in the target PT and increases with the
increase in the HR. No hold time is required for target
PTs of 75 C and above with the decrease in the HR
below 100 C min
)1. The cellular damage is a dominant
function of hold time at target PTs of 60 C and less
B. SHAH and S. BHOWMICK 1756and for HRs of 50 C min
)1 and higher. Total time
(rise, hold and cooling time) plays a major role in
accumulating the cellular injury when the temperatures
are 70 C and above and when the HRs are between
0 C min
)1 and 50 C min
)1. Minimal total treatment
time for complete cellular damage was observed at
target PTs of 60, 65 and 70 C and HRs of 50, 50 and
20 C min
)1, respectively.
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